RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a 'case study'

Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a 'case study'

Add to Collection
RCTs A Ptaszynska, SM Cohen, EM Messing, TP Reilly… - Diabetes Therapy, 2015 - Springer

Chapter : Section2, Section9
Journal Year : 2015
Cited by : 58

… dapagliflozin versus comparator, these data highlight that some well-established and potent risk factors of bladder cancer in patients with T2DM were present, which cannot be ignored. …..... Read More

Keywords : ['type diabetes clinical trial', 'dapagliflozin drug development program', 'assess bladder cancer risk', 'case study']
PubMed Link : https://link.springer.com/article/10.1007/s13300-015-0128-9
Google Scholar Link : https://scholar.google.com/scholar?cites=15643496185584485691&as_sdt=5,39&sciodt=0,39&hl=en&num=20